Instrument Inactif

Communiqués VIVUS, Inc. Nasdaq

Actions

US9285511005

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

VIVUS : Receives Court Approval of Joint Chapter 11 Plan of Reorganization	14/12/20	AQ
VIVUS : Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date	16/11/20	AQ
VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	16/11/20	AQ
VIVUS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure (form 8-K)	13/07/20	AQ
VIVUS INC : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	07/07/20	AQ
VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC	07/07/20	GL
VIVUS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	19/06/20	AQ
VIVUS INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	02/06/20	AQ
VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.	02/06/20	GL
Vivus: 1Q Earnings Snapshot	07/05/20	AQ
VIVUS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	06/05/20	AQ
VIVUS Reports First Quarter 2020 Financial Results	06/05/20	GL
VIVUS : Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt	04/05/20	AQ
VIVUS : to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020	04/05/20	AQ
VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020	01/05/20	GL
VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt	01/05/20	GL
VIVUS INC : Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	01/05/20	AQ
VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	03/04/20	AQ
VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	03/04/20	GL
VitalTech : Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules	03/04/20	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués VIVUS, Inc. Nasdaq

Actions

US9285511005

Communiqués

Filtres